| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9B | $7.4B | $7.8B | $7.3B | $5.6B | $1.2B | $1.2B | $1.1B |
| Cost of Revenue | $5.8B | $5.4B | $5.8B | $5.8B | $4.2B | $3.6B | $3.7B | $3.3B |
| Gross Profit | $2.2B | $2.0B | $1.9B | $1.6B | $1.4B | $0.3B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B |
| Operating Income | $1.6B | $1.4B | $1.4B | $1.0B | $1.0B | $0.2B | $0.2B | $0.2B |
| Net Income | $1.1B | $0.9B | $0.9B | $0.6B | $0.7B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $8.16 | $6.89 | $7.02 | $4.33 | $5.05 | $0.86 | $1.07 | $0.94 |
| EPS (Diluted) | $8.11 | $6.85 | $6.98 | $4.31 | $5.02 | $0.86 | $1.06 | $0.93 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.7B | $17.1B | $14.5B | $14.2B | $13.7B | $11.7B | $10.6B | $9.8B |
| Current Assets | $2.6B | $2.3B | $2.5B | $1.9B | $1.7B | $2.3B | $1.4B | $1.1B |
| Cash & Equivalents | $0.2B | $0.6B | $0.9B | $0.2B | $0.2B | $1.2B | $0.3B | $0.0B |
| Total Liabilities | $8.2B | $9.0B | $7.0B | $7.3B | $7.1B | $5.7B | $5.0B | $4.6B |
| Current Liabilities | $1.0B | $1.2B | $0.8B | $1.0B | $0.8B | $1.0B | $0.5B | $0.6B |
| Stockholders' Equity | $8.5B | $8.1B | $7.5B | $6.9B | $6.5B | $6.0B | $5.6B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.4B | $1.5B | $1.1B | $1.0B | $1.1B | $1.0B | $0.8B |
| Investing Cash Flow | $-0.5B | $-2.8B | $-0.2B | $-1.1B | $-1.9B | $-0.4B | $-0.4B | $-0.7B |
| Capital Expenditures | $0.7B | $0.6B | $0.9B | $0.6B | $0.5B | $0.4B | $0.4B | $0.5B |
| Financing Cash Flow | $-1.7B | $1.1B | $-0.6B | $-0.2B | $-0.1B | $0.2B | $-0.3B | $-0.3B |